BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

LINDEN ADVISORS LP's Holding History (CIK: 0001279396)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 214,048,000 Value ($000) $241,049 Avg Close — Range —
Q3 2025
Shares 175,048,000 Value ($000) $173,094 Avg Close — Range —
Q2 2025
Shares 148,048,000 Value ($000) $138,608 Avg Close — Range —
Q1 2025
Shares 136,798,000 Value ($000) $123,182 Avg Close — Range —
Q4 2024
Shares 102,235,000 Value ($000) $87,514 Avg Close — Range —
Q3 2024
Shares 88,235,000 Value ($000) $73,781 Avg Close — Range —
Q2 2024
Shares 82,235,000 Value ($000) $65,742 Avg Close — Range —
Q1 2024
Shares 79,735,000 Value ($000) $65,625 Avg Close — Range —
Q4 2023
Shares 57,310,000 Value ($000) $48,500 Avg Close — Range —
Q3 2023
Shares 55,810,000 Value ($000) $41,974 Avg Close — Range —